12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

DV-601: Phase Ib data

An open-label, dose-escalation, Polish Phase Ib trial in 14 patients with chronic HBV infection showed that DV-601 was well tolerated and induced...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >